Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial. - Denkinger CM; Janssen M; Schäkel U; Gall J; Leo A; Stelmach P; Weber SF; Krisam J; Baumann L; Stermann J; Merle U; Weigand MA; et al. (Nature cancer, 2023)